A monoclonal antibody specific for E2 of CSFV isolates of group 2, not of group 1.
This mAb epitope is located in hypervariable antigenic region 1 (HAR1).
Glu713 within this epitope is critical for specific recognition.
Antiserum from vaccine C-strain failed to neutralize group 2 strains.
Antiserum of chimeric C-strain carrying this HAR1 had good cross-neutralizing ability.